177Lu-DOTATATE peptide receptor radionuclide therapy in metastatic or advanced and inoperable primary neuroendocrine tumors of rare sites by Pradeep Thapa, Rahul Parghane, Sandip Basu

Subjects: Get full text

Improved Quality of Life in Patients Treated with Peptide Radionuclides by T. Traub-Weidinger, M. Raderer, M. Uffmann, P. Angelberger, A. Kurtaran, M. Leimer, J. Preitfellner, R. Dudczak, I. Virgolini

Subjects: Get full text

Targeted radionuclide therapy and diagnostic imaging of SSTR positive neuroendocrine tumors: a clinical update in the new decade by Katherine N. Haugh, Alexis M. Sanwick, Ivis F. Chaple

Subjects: Get full text

Parapharyngeal space meningioma by Pranjal Rai, MD, Niyati Pokar, MBBS, Animesh Awadhiya, MBBS, Joe Joseph, MD, Dhairya A Lakhani, MD

Subjects: Get full text

Current insights and future directions in systemic therapies for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) in children and adolescents: a critical review of advanc... by Michaela Kuhlen, Katharina Karges, Marina Kunstreich, Maximilian Schmutz, Antje Redlich, Rainer Claus, Constantin Lapa

Subjects: Get full text

Peptide receptor radionuclide therapy for ectopic Cushing’s syndrome caused by metastatic neuroendocrine neoplasms by Emma Boehm, Terry Hung, Tim Akhurst, Ramin Alipour, Cherie Chiang, Rodney J Hicks, Michael S Hofman, Aravind S Ravi Kumar, Nirupa Sachithanandan, Javad Saghebi, Michael Michael, Grace Kong

Subjects: Get full text

Clinical efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in thyroglobulin-elevated negative iodine scintigraphy: A “not-so-promising” result compared to GEP-NETs... by Sandip Basu, Rahul Parghane, Chinna Naik

Subjects: Get full text

Peptide receptor radionuclide therapy with 177Lu-DOTATATE for metastatic neuroendocrine tumor occurring in association with multiple endocrine neoplasia type 1 and cushing's syndro... by Chinna Naik, Sandip Basu

Subjects: Get full text

First-in-human experience of radiopharmaceutical therapy with [177Lu]Lu-DOTATATE in patients with advanced multiple myeloma by Wendy Delbart, Marie Vercruyssen, Rachele Danieli, Clémentine Marin, Zéna Wimana, Nathalie Meuleman, Patrick Flamen, Erwin Woff, Ioannis Karfis

Subjects: “…Peptide receptor radionuclide therapy…”
Get full text

Metastatic neuroendocrine tumor with extensive bone marrow involvement at diagnosis: Evaluation of response and hematological toxicity profile of PRRT with 177Lu-DOTATATE by Sandip Basu, Rohit Ranade, Pradeep Thapa

Subjects: Get full text

Clinical Guideline for Precision Nuclear Medicine Diagnosis and Treatment of Neuroendocrine Neoplasms (2025 Edition) by Chinese Society of Nuclear Medicine in Chinese Medical Association, Chinese Neuroendocrine Tumor Society in China International Exchange and Promotive Association for Medical and Health Care

Subjects: Get full text

The PANEN nomogram: clinical decision support for patients with metastatic pancreatic neuroendocrine neoplasm referred for peptide receptor radionuclide therapy by Aviral Singh, Aviral Singh, Aviral Singh, Sebastian Sanduleanu, Harshad R. Kulkarni, Thomas Langbein, Philippe Lambin, Richard P. Baum

Subjects: Get full text

Prediction of lesion-based response to PRRT using baseline somatostatin receptor PET by Anas Aouf, Tilman Speicher, Arne Blickle, Moritz B. Bastian, Caroline Burgard, Florian Rosar, Samer Ezziddin, Amir Sabet

Subjects: Get full text

177Lu-DOTATATE peptide receptor radionuclide therapy in patients with borderline low and discordant renal parameters: Treatment feasibility assessment by sequential estimation of t... by Chinna Naik, Sandip Basu

Subjects: Get full text

“Cold” Somatostatin Analogs in Neuroendocrine Neoplasms: Decoding Mechanisms, Overcoming Resistance, and Shaping the Future of Therapy by Sara Massironi, Manuela Albertelli, Iderina Hasballa, Piero Paravani, Diego Ferone, Antongiulio Faggiano, Silvio Danese

Subjects: Get full text

Very low thyroglobulin level and rare metastatic location in radio-iodine refractory DTC should raise suspicion for initial misdiagnosis by Seyed Rasoul Zakavi, Haniye Elahifard, Nasrin Raeisi, Naime Ataei, Amin Saber Tanha

Subjects: Get full text

Unmasking insulinoma following commencement of somatostatin analogues in malignant neuroendocrine tumours by Isuru Gamage, Emma Boehm, Gaurav Ghosh, Grace Kong, Michael Michael, HuiLi Wong, Oliver Piercey, Nirupa Sachithanandan

Subjects: Get full text

Safety, dosimetry, and efficacy of an optimized long-acting somatostatin analog for peptide receptor radionuclide therapy in metastatic neuroendocrine tumors: From preclinical test... by Wei Guo, Xuejun Wen, Yuhang Chen, Tianzhi Zhao, Jia Liu, Yucen Tao, Hao Fu, Hongjian Wang, Weizhi Xu, Yizhen Pang, Liang Zhao, Jingxiong Huang, Pengfei Xu, Zhide Guo, Weibing Miao, Jingjing Zhang, Xiaoyuan Chen, Haojun Chen

Subjects: Get full text

Prevalence of hitherto unknown brain meningioma detected on 68Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and expl... by Rahul V. Parghane, Sanjay Talole, Sandip Basu

Subjects: Get full text

Prevalence of hitherto unknown brain meningioma detected on 68Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and expl... by Rahul V Parghane, Sanjay Talole, Sandip Basu

Subjects: Get full text